Academician
MEHMET MURAT KIŞLA
ARAŞTIRMA GÖREVLİSİ
ANKARA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
Article counts come from two sources, each shown separately: YÖKSİS (academic declarations) and OpenAlex (open scholarly catalog). Patents and artistic activities are listed under the Works tabs below.
Index quartiles
Scopus (SJR)
14 Total
- Q1 5
- Q2 3
- Q3 6
- Q4 0
Other counts
- YÖKSİS rows 26 Q1 0 Q2 0 Q3 0 Q4 0
WoS (JCR)
12 Total
- Q1 2
- Q2 5
- Q3 3
- Q4 2
Other counts
- YÖKSİS rows 24 Q1 0 Q2 0 Q3 0 Q4 0
TR Index
3 articles
Other counts
- YÖKSİS rows 6 articles
OpenAlex citation percentiles
Top 1% articles
0
Top 10% articles
6
Avg percentile
63.7%
Articles with percentile
24
OpenAlex citation percentile; covered works only (~52%).
What do these indicators mean?
- Q1–Q4: the quartile of the journal in the given index (Scopus/WoS). Q1 = top 25%, Q4 = bottom 25%.
- Top 1% / top 10%: number of works among the top 1% or 10% most-cited worldwide in the same field and year.
- Avg percentile: mean citation percentile of the works (100 = highest).
- Source: index quartiles from Scopus/WoS and TR Index flags; citation percentiles from OpenAlex.
Proceedings
Conference proceedings recorded in YÖKSİS.
Records
- 2022 FENOTİYAZİN TÜREVİ BİLEŞİKLERİN SENTEZLERİ, ANTİKANSER AKTİVİTELERİ VE MOLEKÜLER DOKİNG ANALİZLERİ
- SYNTHESIS, MOLECULAR MODELLING STUDIES AND ANTICANCER ACTIVITY OF NOVEL PHENOTHIAZINE DERIVATIVES WITH CHOLINERGIC MODULATORY ACTION
- 2021 SYHTHESIS, ANTINEOPLASTIC ACTIVITY AND MOLECULAR DOCKING STUDIES OF NOVEL INDOLE- THIAZOLIDINEDIONE DERIVATIVES
- Synthesis and Investigation of Anti-Cancer Activity of Novel Substituted Alkylsulfonyl 1H-benzo[d]imidazole Derivatives in MCF-7 Breast Cancer Cells
- Synthesis and investigation of anti-cancer activity of novel substituted alkylsulfonyl 1H- benzo[d]imidazole derivatives in MCF-7 breast cancer cells
- 2018 Molecular, biochemical and in silico analyses of commercial and novel phenothiazines as anticancer agents